23andMe reported a $217 million net loss during its fiscal year 2022, which ended March 31, compared with $184 million during the prior year.
The consumer genetics company also posted a loss of $70 million during its fourth quarter, compared with $67 million during Q4 2021. 23andMe attributed the increase in net loss during the quarter to increased operating expenses driven by sales and...
Singapore-headquartered online pharmacy platform SwipeRx has raised $27 million in a Series B funding round led by MDI Ventures.
It also received backing from global investors, including the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, and Susquehanna International Group.
WHAT IT DOES
Formerly mClinica Pharmacy Solutions, SwipeRx operates an online platform where...
Tohoku University's Tohoku Medical Megabank Organization, pharmaceutical firms Daiichi Sankyo and Takeda Pharmaceutical Co., and medical IT company MICIN have started a collaborative research project to track long-term lifestyle habits to drive the creation of new drugs.
According to a press statement, the organisations will loan wearable tracking devices to about 2,000 participants. Over a year...
ICT provider Fujitsu has partnered with research institute Riken in Japan to jointly work on new-generation IT drug discovery technology to accelerate digital transformation in drug discovery.
According to a press statement, the organisations will utilise the supercomputer Fugaku, which they have developed together in the past decade, along with simulation AI technologies. Through these...
Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to offer Kaiku's tools for symptom management and support to clinics and patients.
Finnish-born Kaiku provides a digital platform where patients can input their symptoms as they undergo cancer treatment, receive feedback for lower-acuity concerns and keep the care team...
Prescription digital therapeutics startup MedRhythms has entered into a licensing agreement with Biogen to develop and commercialize its MR-004 product, which aims to improve mobility for people with multiple sclerosis (MS).
Under the deal, MedRhythms would receive a $3 million upfront payment from Biogen, with the potential to earn up to $117.5 million if certain development and commercial...
Decentralized clinical trial company Curebase raised $40 million in a Series B round led by Industry Ventures.
Acrew Capital, World Innovation Lab, Positive Sum, Gaingels, GGV Capital, Bold Capital and Xfund participated in the funding, which also included a strategic investment from pharma giant Gilead Sciences. The round brings Curebase's total raise to $59 million.
WHAT IT DOES
Curebase offers...
Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. to broaden the access to its core technology that transforms smartphones into IVD devices.
On Wednesday, the company announced that the publicly-listed Japanese pharma company became its latest partner and shareholder who will help expand its business globally and promote its...
Prescription-focused Waltz Health launched Tuesday with $35.4 million in Series A funding. The round was led by GV, with participation from Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, Twine Ventures and individual healthcare executive investors.
The startup's first product is called Marketplace Search, a search engine that pharmacies can provide to their consumers...
Flipkart Health+, the digital health business of e-commerce platform Flipkart Group, has launched its mobile health app.
This comes three months after the company first entered the healthcare space by acquiring a minor stake in e-pharmacy startup SastaSundar.
According to a press statement, the Flipkart Health+ app is providing access to medicines and other healthcare products and services. It...